RECRUITING: Rett-T antioxidant study – Canada
Posted: Thu Sep 03, 2026 10:47 pm
Status: RecruitingStudy: Antioxidant cocktail (Rett-T) versus placebo
Registry number: NCT04041713
Location: Holland Bloorview Kids Rehabilitation Hospital, Toronto, Canada
Participants: Females aged 2–21 years who are at least partly ambulatory
What is being studied?
This pilot study is evaluating the safety and possible effect of an antioxidant combination on core motor difficulties in Rett syndrome. Researchers are also examining biological markers of safety and treatment response.
Contact: Faiza Khawaja — +1 416 425 6220 ext. 3526 — fkhawaja@hollandbloorview.ca
Official study record: https://clinicaltrials.gov/study/NCT04041713
Information checked 3 September 2026. Eligibility is determined by the study team. Families should confirm the latest status and speak with their Rett clinician before considering enrolment.
Registry number: NCT04041713
Location: Holland Bloorview Kids Rehabilitation Hospital, Toronto, Canada
Participants: Females aged 2–21 years who are at least partly ambulatory
What is being studied?
This pilot study is evaluating the safety and possible effect of an antioxidant combination on core motor difficulties in Rett syndrome. Researchers are also examining biological markers of safety and treatment response.
Contact: Faiza Khawaja — +1 416 425 6220 ext. 3526 — fkhawaja@hollandbloorview.ca
Official study record: https://clinicaltrials.gov/study/NCT04041713
Information checked 3 September 2026. Eligibility is determined by the study team. Families should confirm the latest status and speak with their Rett clinician before considering enrolment.